We are honored to be awarded both Pan-Asia Fund Manager of the Year and Asia Private Credit Fund Manager of the Year by SuperReturn. These accolades recognize the evolution of our platform in Asia and our track record as a partner of choice for growing businesses in the region. Since first establishing our Asia platform in 2005, we have built one of the deepest teams and pools of capital in the region. Today Bain Capital has over 180 investment professionals across our businesses in Asia operating from 10 offices. Our goal is to deliver exceptional returns for our investors by combining strategic insights, operational expertise, industry knowledge, and flexible capital with our deep local in-market teams and global resources. We started our platform in Asia with Private Equity where we have had great success and over the last decade have also expanded to be a leader in Special Situations and Direct Lending – demonstrating the strength of our model across asset classes. This growth underscores both our conviction in Asia and the opportunities we see to further broaden our platform. Thank you again to SuperReturn for this recognition. #Asia
Bain Capital
Financial Services
Boston, MA 328,322 followers
Committed to lasting impact
About us
We are one of the world’s leading private investment firms with approximately $185 billion in assets under management that creates lasting impact for our investors, teams, businesses and the communities in which we live. Founded in 1984, we pioneered a consulting-based approach to private equity investing, partnering closely with management teams to offer the insights that challenge conventional thinking, build great businesses and improve operations. Over time, we have organically expanded this approach across asset classes to build one of the strongest alternative asset platforms in the world. Today, our teams strive to create value through private equity, public equity, fixed income, credit, venture capital and real estate investments across multiple sectors, industries, and geographies. We believe that our people and the shared values we’ve espoused since our founding remain the core of our competitive advantage. This has empowered us to deliver an enduring impact to a diverse group of investors including pensions, endowments, foundations and individuals.
- Website
-
http://www.baincapital.com
External link for Bain Capital
- Industry
- Financial Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 1984
- Specialties
- Private equity, venture capital, public equity, leveraged debt asset, global macro asset, Real Estate, Life Sciences, Double Impact, Investment, and Alternative Investment
Locations
-
Primary
Get directions
200 Clarendon Street
Boston, MA 02116, US
-
Get directions
590 Madison Avenue
42nd Floor
New York, NY 10022, US
Employees at Bain Capital
Updates
-
The launch of Kailera Therapeutics marks a significant milestone in the rapidly evolving metabolic space. This company is dedicated to advancing a clinically validated portfolio of therapies for chronic weight management, supported by an experienced team led by Ron Renaud, and joined by former Gilead Sciences CEO John F. Milligan, Ph.D as Chairman of the Board. It also builds on our experience establishing innovative Life Sciences companies from the ground up. We’re thrilled to support Kailera Therapeutics's growth, innovation, and mission to help people reclaim their health and live their lives to the fullest.
Introducing Kailera Therapeutics-- a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. Launching today with our $400 million Series A financing co-led by Atlas Venture, Bain Capital Life Sciences, and RTW Investments, LP, with participation from Lyra Capital, we are developing several clinical-stage injectable and oral therapies that demonstrated potential as best-in-class treatments for chronic weight management. In conjunction with our launch, we are thrilled to announce our initial executive leadership team appointments including: Ron Renaud, Chief Executive Officer Doug Bakan, Ph.D., Chief Technology Officer Paul Burgess, Chief Operating Officer and Chief Business Officer Paula Cloghessy, SPHR, SHRM-SCP, Chief People Officer Scott Wasserman, M.D., Chief Medical Officer Additionally, we are excited to welcome industry veteran John F. Milligan, Ph.D., as our Board Chair. Our leadership team and board of directors have deep industry experience and a track record of building successful companies, positioning Kailera to advance innovative therapies with the potential to meaningfully impact both quality of life and overall health for many people. Thank you to our dedicated team, board, and investors for supporting our mission to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health! Learn more: https://lnkd.in/eRSBh7yX
-
At the start of this school year, more than 3,000 City Year members returned to serve in schools across the US, the UK, and South Africa. They play critical roles in the classroom and community, mentoring students in under-resourced schools, developing civic leaders, and ensuring equal access to learning opportunities. We believe this work is essential, which is why over the last three decades, Bain Capital and our people have been proud to support City Year’s growth by contributing more than $65 million, volunteering, and sharing our experience as advisors and board members. Thanks to City Year, children across the globe are returning to school with the resources required to thrive. Learn more about our partnership: https://lnkd.in/eq-y_Zet
-
-
-
-
-
+1
-
-
We are excited to announce a joint venture with NEINOR HOMES, the leading listed residential property developer in Spain providing development and management services to our growing portfolio of housing across the country through our portfolio company Promociones Habitat. With demand for housing growing across Spain, this joint venture will help develop lasting communities for the high concentration of Spanish households seeking the dream of homeownership. Bain Capital is a global player in real estate with significant investments and a clear strategy in Spain. #RealEstate #Housing #BainCapital You can read more about the announcement here: https://lnkd.in/e9xBVyzF
-
Bain Capital reposted this
Recently had the pleasure of catching up with Kirk Falconer from Buyouts to discuss what we’re calling the "golden age of flexible capital." We dove into the structural and macro trends making this such an exciting time for the partnership-focused, flexible capital solutions our Special Situations team offers. For us, driving value is about building win-win capital solutions and leveraging the dedicated business-building capabilities that help growing companies achieve their full potential. Check out the full article below. https://lnkd.in/eVYukPkr
-
Across the healthcare and life sciences space, we strive to support companies that drive medical innovation to improve the lives of patients with unmet medical needs. That’s why we’re excited to partner with Serán BioScience, a true end-to-end provider of manufacturing services for complex drug products. In a conversation with Fierce Pharma, Will Cozean discussed how our investment is emblematic of the unique and innovative capabilities the company brings to drug development and clinical manufacturing. We look forward to an impactful partnership with Dan Smithey, PhD and the Serán team and the opportunity to leverage our experience and resources to support the company’s continued growth. Learn more about our investment in Serán here: https://lnkd.in/ezezTXY8
Today we're excited to announce a strategic growth transaction that will support build out of a state-of-the-art commercial scale spray drying, particle engineering and finished dose manufacturing facility at Serán BioScience's campus in Bend, Oregon. Bain Capital Life Sciences (“Bain Capital”) led the transaction, while existing investor Vivo Capital remains a key shareholder in the company. The partnership will support Serán’s continued growth and will enable us to provide integrated capabilities across multiple drug delivery and final dose formats providing enabling and accelerated solutions for clients from early development to commercial supply. The new facility will be completed in 2026 and will support oral, pulmonary, and nasal delivery modalities with commercial-scale particle engineering solutions, including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, as well as comprehensive finished dose capabilities including granulation, tableting, coating, encapsulation, powder filling, including for modified release products. An adjacent facility, already under construction, will enable extensive packaging, labeling, serialization, and distribution capabilities. Read the full release here https://hubs.li/Q02Q5Lr80 #CDMO
-
-
Women at all levels across our business units in Europe gathered for our second-annual Women’s Offsite to connect as a community, celebrate collective accomplishments, and share their stories of seeking success in work and life. We believe these events are essential—for our firm and portfolio companies—to foster two-way mentorship, build an inclusive culture, and support every team member’s path forward. We were thrilled to welcome House of HR CEO, Rika Coppens, GAIL's COO, Marta Pogroszewska, and Abi Tierney, distinguished British Civil Servant and CEO of the WRU - Welsh Rugby Union who each shared invaluable insights and reflections from their personal experiences and career journeys. #BainCapital #Culture #WomeninFinance
-
-
Over the last fifty years, RSB Transmissions (I) Ltd. has become the global partner of choice for Original Equipment Manufacturers, renowned for its innovation in automotive engineering, top-tier manufacturing capabilities, and unwavering commitment to quality. Over the past eighteen months, we’ve had the privilege of building a strong relationship with RSB’s founders and management team as we developed a shared vision for the company's continued growth into a global, diversified engineering platform. Read the full announcement: https://lnkd.in/eVMdz3q2
-
-
Sound governance and active stewardship are more vital than ever as we grow and shape the future trajectory of our companies and investments within the context of today’s complex issues. Working in partnership, we hold ourselves accountable for driving value while maintaining high integrity. See examples of our 2024 #ESG Report, including practical perspectives Kimberly McCaslin and Jennifer (Wilson) Davis. https://lnkd.in/egkcj9XC
-
This year at Mingtiandi - Asia real estate intelligence’s Singapore Forum, Michael Hui and Man Kinoshita spoke about the macroeconomic and structural dynamics driving our ability to provide bespoke financing solutions across the capital structure to real estate owners and operators in Asia. Michael emphasized the opportunity for our Special Situations team to serve as a partner for growing businesses facing a critical undersupply of flexible capital solutions. Man highlighted our strategic focus on maximizing the value of Japanese corporations' vast array of real estate assets. Learn more about how we're navigating these evolving markets: https://lnkd.in/gDANnz4g #RealEstate #SpecialSituations
-